Financials data is unavailable for this security.
View more
Year on year Medclair AB grew revenues 60.13% from 24.89m to 39.85m while net income improved from a loss of 5.00m to a smaller loss of 2.79m.
Gross margin | 61.65% |
---|---|
Net profit margin | 5.16% |
Operating margin | -5.78% |
Return on assets | 3.88% |
---|---|
Return on equity | 4.64% |
Return on investment | 4.64% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Medclair AB fell by 687.00k. However, the company earned 5.26m from its operations for a Cash Flow Margin of 13.20%. In addition the company used 5.45m on investing activities and also paid 493.00k in financing cash flows.
Cash flow per share | 0.101 |
---|---|
Price/Cash flow per share | 19.24 |
Book value per share | 0.6486 |
---|---|
Tangible book value per share | 0.2445 |
More ▼
Balance sheet in SEKView more
Current ratio | 1.88 |
---|---|
Quick ratio | 1.42 |
Total debt/total equity | 0.0027 |
---|---|
Total debt/total capital | 0.0027 |
More ▼